Invadopodia are membrane protrusions dynamically assembled and retracted by invasive cancer cells in contact with extracellular matrix (ECM). Invadopodia are enriched for the structural proteins actin and cortactin, as well as metalloproteases such as MT1-MMP, whose function is to degrade the surrounding ECM. During metastasis, invadopodia are necessary for cancer cell intravasation and extravasation. While signaling pathways involved in the assembly and function of invadopodia are well studied, few studies address control of invadopodia dynamics and how the cell-ECM interactions contribute to cell movement. Using iterative analysis based on timelapse microscopy and mathematical modeling of invasive cancer cell behaviors, we found that the cells oscillate between invadopodia presence and cell stasis, which we term invadopodia state and invadopodia absence during cell translocation (migration state). Our data suggests that β1integrin-ECM binding controls the duration of each of the two states. By changing the concentration of cross-linkers in 2D and 3D cultures, we can generate ECM where 0-0.92 of total lysine residues are cross-linked. Using ECM with a range of cross-linking degrees we demonstrate that the dynamics of invadopodia-related functions have a non-linear (biphasic) relationship to ECM cross-linking. At intermediate levels of ECM cross-linking (0.39), cells exhibit rapid invadopodia protrusion-retraction cycles and rapid calcium spikes, which in turn lead to more frequent MT1-MMP delivery, causing maximal invadopodia-dependent ECM degradation. Additionally, intermediate cross-linking leads to more frequent oscillations between invadopodia and migration. In contrast, both extremely high or low levels of cross-linking lead to slower invadopodia-related dynamics and lower ECM degradation levels. Collectively, these data suggest that small physical differences in extracellular environment non-linearly translate to differences in the dynamics of cancer cell behaviors. Understanding conditions under which invadopodia can be reduced or eliminated from the tumor microenvironment by subtle environment-targeting treatments may lead to combination therapies for preventing metastatic spread.
Introduction
Invadopodia (1) are dynamic membrane protrusions involved in the invasive motility of cancer cells. Their function is to degrade the surrounding ECM. In tumors in vivo, they are necessary for cancer cell intravasation (2) and extravasation (3) from the blood vessels. In vitro, invasive cancer cells assemble invadopodia when grown on various ECM components and in the presence of growth factors. Invadopodia have appearance of puncta rich in actin, actin-regulatory proteins (e.g. cortactin), tyrosine kinases and proteases (eg. MT1-MMP). While a large number of the invadopodial components are found in other motility-related structures such as focal adhesions and lamelipodia, the unique feature of invadopodia is the high ECM-degrading activity.
Assembly and maturation of individual invadopodium has been well studied (4, 5) using 2D in vitro assays. The invadopodium precursors, consisting of cortactin, cofilin and N-WASP, are first assembled (6) . The structure is then stabilized via focal adhesion proteins such as β1integrin by binding the structure tip to the ECM (7, 8) . During invadopodia maturation, cortactin phosphorylation leads to continuous actin polymerization and MT1-MMP recruitment to the tip of invadopodia via late endosomes (9) . Transmembrane MT1-MMP assures focalized ECM degradation of the surrounding ECM and invadopodia becomes mature and functional (at ~50 minutes) (6) . During ECM degrading activity, mature invadopodia exhibits SOCE-driven calcium spikes, which are necessary for MMP recycling to the plasma membrane (10) . Mature invadopodia also exhibits physical force on ECM, by means of protrusion-retraction cycles, during which actin filaments polymerize (protrusion) or depolymerize (retraction) (11). Physical and proteolytic ECM remodeling by invadopodia are coordinated via cortactin (de)phosphorylation and positive feedback from MT1-MMP (12, 13) .
The assembly of invadopodia, as well as level of ECM degradation were shown to be linked to the ECM properties such as rigidity, density and cross-linking (14) (15) (16) . This points to the essential role in adhesion-based signaling in the invadopodia progression. A recent study of β1-integrin role in invadopodia strengthened this link, demonstrating that β1-integrin is localized to invadopodia and directly links the structure to ECM. While elimination of β1-integrin does not inhibit invadopodia precursor assembly, it disables invadopodia maturation and ECM-degrading function.
Recent studies of invadopodia in 3D (13, 17, 18) and in vivo (2, 19) demonstrated that invadopodia are present at the front of the cells migrating in MMP-dependent manner. Depending on the ECM parameters including density, fiber size, stiffness and/or cross-linking, such migration can result in a broad range of speeds (6-30 μm/hour for breast carcinoma) (13, 20, 21) . In vivo, presence of invadopodia was also shown to be highly dependent on ECM cross-linking (2) . While the studies of 3D and in vivo invadopodia established the link between invadopodia and cell movement, it is not known if cells which assemble invadopodia can translocate the cell body simultaneously or they move and assemble invadopodia in a sequential manner.
We have used iterative cycles of time-lapse microscopy and mathematical modeling towards addressing the role of invadopodia dynamics and ECM cross-linking in invasive cell motility. We found that the dynamics of invadopodia assembly and function have a non-monotonic (biphasic) relationship to an increase in ECM cross-linking. Furthermore, we show that the presence of invadopodia and the migration of cells are mutually exclusive, with level of active ß1integrin controlling the duration of each of the two states. We demonstrate that partial blocking of β1-integrin increases the duration of migration and shortens the period of active ECM by inhibiting invadopodia activity. Taken together, our results suggest that invadopodia-driven, MMPdependent motility consists of oscillations between a) sessile invadopodia assembly and degradation and b) migration. Modulation of β1-integrin activity or ECM cross-linking can be used to reduce or eliminate invadopodia, which are necessary for intravasation and metastasis (2) .
Results

Breast cancer cells switch from migration to invadopodia-based ECM degradation
To determine whether cell migration occurs simultaneously or sequentially with invadopodia assembly, we acquired time-lapse recordings of metastatic breast carcinoma cells, MTLn3, engineered to express fluorescent cortactin (Cerulean-cortactin-MTLn3). Our recordings of >100 cells indicated that cells oscillate between migration and invadopodia states. A representative cell in which migration and invadopodia assembly were tracked simultaneously is shown in Figure  1A -C and Movie S1. In the beginning, the cell migrates relatively fast (>20 µm/h), assembling some short-living (<10 min lifetime) invadopodia precursors ( Figure 1D ). Starting at 380 minutes, speed of the cell decreases (<2 µm/h movement) and the number of mature invadopodia which degrade ECM increases ( Figure 1D ). We hypothesized that the frequency of switching between invadopodia state and migration state will be controlled by ECM cross-linking (2, 15, 22) and ECM-cell interactions via integrin (20) (21) (22) (23) (24) (25) . Towards this goal, we developed a phenomenological, non-dimensional mathematical model (see Supplementary Materials) , based on the observed state oscillations and prior studies on ECM-cell interactions in 2D, 3D and in vivo environments.
The dynamic variables used in the model were the concentration of ECM interacting with the cell (represented by CECM), probability of cell being in invadopodia state (represented by I) and probability of cell being in migration state (represented by M). Cell-ECM interactions were assumed to be constant for specific ECM conditions and addressed by the adhesion constant Ka. To address the dynamic properties of the migration/degradation oscillations, we varied the degree of ECM cross-linking (expressed as X, the ratio of cross-linked lysine residues to the total number of lysine residues). We additionally introduced model fitting parameter (n), which is used to fit the model to different ECM dimensionalities. Parameter n was further experimentally determined to be 11 in 2D assays, and 12 in 3D conditions (Figure S1).
Figure 1E
shows one run of the model simulation for a cell oscillating between invadopodia (blue line) and migration (red line). The dynamics of the transition between invadopodia and migration states observed at a single cell level (Figure 1D ) is recapitulated and extended in the repeated cycles of migration/invadopodia that model demonstrates. Figure 1F summarizes the model simulations for varying X, n and oscillation frequencies. The model suggests that an increase in ECM cross-linking will enable a biphasic change in the frequency of migration/invadopodia switches in cells. Such a prediction implies that at intermediate cross-linking X, the number of switches from migration to degradation and vice versa will reach a maximum (Figure 1F , yellow regions), which will in turn result in the maximal number of degraded punctae.
Invadopodium maturation and ECM degradation biphasically conform to ECM cross-linking in 2D and 3D
To test if predictions of our model are supported in experimental invadopodia assays, we measured invadopodia assembly and function in ECM with increasing cross-linking degrees. Breast carcinoma MTLn3 cells were plated on a thin fluorescent gelatin layer cross-linked from a 0 to 0.92 cross-linking degree (Figure S2A) , using the chemical cross-linker glutaraldehyde (GTA). At 18 hours after plating, the number of invadopodia precursors, mature invadopodia and ECM degradation were measured (Figure 2A-D) . The number of invadopodia precursors reached a plateau at 0.39 cross-linking degree, while the number of mature invadopodia showed a strong biphasic trend with the increase in cross-linking (Figures 2C, D) . The peak of the biphasic trend is at the intermediate cross-linking level (0.39) for both the total number of spots degraded over 18 hours ( Figure 2C ) and for mature invadopodia present at the time of cell fixation ( Figure 2D) . Moreover, the portion of invadopodia precursors that mature and degrade ECM, reported as invadopodia stability ratio, is at its maximum at the cross-linking degree of 0.39 (Figure 2E) . Trend in increase of total area of degradation further confirms that the increase in the cross-linking degree has a biphasic relationship to invadopodia maturation and degradation. Our results were also confirmed using two additional human breast carcinoma cell lines, MDA-MB-231 and Hs-578T ( Figure 2F ). All three cell lines presented biphasic distributions of invadopodia-driven degradation with increased cross-linking, with the peak at intermediate cross-linking (X = 0.39).
In conclusion, as predicted in our model, the experimental data show a biphasic trend in invadopodia degradation with increased cross-linking ratio.
Results of the 2D invadopodia assay were then validated in 3D invadopodia assay, using FITC-DQ-collagen cross-linked using transglutaminase II from a 0 to 0.87 crosslinking degree (Figure S2B, C) (2, 13, 26, 27) . Colocalization of the FITC-DQ collagen I signal with cortactin, actin, and MT1-MMP confirmed that the 3D collagen degradation was due to invadopodia activity ( Figure 3A) . Invadopodia-based degradation also followed a biphasic trend in a 3D environment, with maximum degradation present at the intermediate level of crosslinking (0.36) ( Figure 3B) . Collectively, our model and experimental, end-point measurements showed that intermediate cross-linking degree results in the increase of total number of invadopodia maturing and degrading ECM over time. We hypothesized that this can be a result of faster dynamics of invadopodia activities, such as faster protrusive cycles and/or more frequent delivery of MT1-MMP.
Frequency of invadopodium protrusion-retraction cycles changes biphasically with increase in ECM cross-linking
To assess the effect of ECM cross-linking on invadopodia protrusion-retraction cycles, fluorescence intensity of cortactin punctae (Movie S2) was monitored in MTLn3 cells at various gelatin cross-linking degrees (Figure 4) . Cortactin signal fluctuations at invadopodia, reflecting cycles of protrusion-retraction, were filtered ( Figure 4B ) and analyzed by autocorrelation ( Figure  4C) . Results show average frequencies of protrusion-retraction cycles of approximately 2.5 mHz at low or high (0.18 or 0.69) cross-linking degrees and significantly higher frequency of 3 mHz at intermediate cross-linking ( Figure 4D ). This reflects significantly faster protrusion-retraction cycles and suggests that the dynamics of invadopodia protrusive cycles is in direct relationship to ECM cross-linking ( Figure 4D) . Combined with results shown in Figures 2 and 3, this data also suggests that increased degradation at intermediate ECM cross-linking may be the consequence of faster protrusive cycles.
Next, we tested if the increase in ECM cross-linking affects proteolytic degradation of ECM by increased dynamics of calcium spikes and consequent MT1-MMP recycling to the plasma membrane (10) .
Calcium wave frequency biphasically changes with increase in ECM cross-linking
SOCE-dependent calcium spikes were recently shown to be essential both for precursor assembly via Src activation, as well as MT1-MMP recycling to the plasma membrane during ECM degradation (10) . As the calcium channels are commonly mechanosensitive (28) (29) (30) and calcium spiking can be influenced by ECM (31) , we hypothesized that the frequency of calcium spikes will reach the peak at cross-linking degree of 0.39, in coordination with protrusion-retraction dynamics. To test this, we monitored calcium spikes in MTLn3 cells with invadopodia, recording Fluo-4-AM signal at different cross-linking degrees (Movie S3; Figure 5A, B) . Dominant frequencies of calcium spikes were determined by power spectrum analysis ( Figure 5C) . Consistent with our model, calcium spikes are fastest at the intermediate cross-linking level ( Figure 5D ). Next, we tested if the fastest calcium spikes result in a more frequent delivery of MT1-MMP vesicles to the invadopodial plasma membrane.
MT1-MMP containing vesicles delivery to the plasma membrane is biphasically regulated by ECM cross-linking
MT1-MMP is recycled by acidic late endosomes to the tip of mature invadopodia, where it is exocytosed to the neutral environment. We tested the MT1-MMP delivery rate in MTLn3 cells using pH-sensitive MT1-MMPpHluorin. This fluorescent protein marks exocytic events of MT1-MMP, which appear as GFP-positive, blinking spots colocalized with the invadopodia (32) . Exocytosis of MT1-MMPpHluorin vesicles was monitored at different cross-linking ratios (Movie S4; Figure 5E , F) to calculate the average vesicle delivery rate for each condition. At cross-linking ratio 0.39, MT1-MMP-vesicles were delivered more frequently compared to other cross-linking ratios (Figure 5F, G) . Interestingly, frequencies of calcium spikes and MT1-MMP vesicle delivery operate in the similar range, suggesting a coordination between cycles of calcium oscillation and vesicle delivery (31) .
Collectively, our data suggests that frequencies of protrusive cycles in invadopodia as well as frequencies of calcium spikes and MT1-MMP delivery to the invadopodial plasma membrane change in concert and are controlled by ECM cross-linking.
Switching between migration and invadopodia states is regulated by β1-integrin activity
The coordinated relationship between ECM properties and invadopodia dynamics and function suggest a central role for the outside-in signaling provided by ECM-integrin interactions. As mentioned above, β1-integrin is localized to invadopodia and in its absence, invadopodia maturation and ECM-degrading function are disabled (7) . We hypothesized that ECM-integrin β1 interactions are the master regulator of invadopodia dynamics and consequently, the length of time that cell will spend in invadopodia state. We next tested this hypothesis in our model as well as experimentally.
In our model, the effect of cell-ECM interaction on invadopodia dynamics was examined by varying the adhesion constant (Ka) from 1 (Figure 1E ) to 0.2 and 0.01 s -1 (Figure 6A) . A decrease in Ka reflects lower cell-ECM adhesion strength. While modifying ECM cross-linking alters adhesion strength externally, by changing the number of ECM molecules proximal to the cell, adhesion strength can also be targeted by modifying the integrin ability to bind ECM. The model results suggest that a decrease in adhesion strength (Ka =0.2) will cause a decrease in the period spent in the invadopodia state, simultaneously increasing the time spent in migration state to the point where invadopodia is completely eliminated and the cell continuously migrates (Ka =0.01).
To test the simulation results, β1-integrin ability to bind to the ECM was increasingly blocked using different doses of a monoclonal blocking antibody (4B4). The extent of invadopodia degradation and average lengths of both invadopodia and migration states were measured at various doses of 4B4. Results show that with increasing concentration of 4B4, average time that a cell spends in invadopodia state decreases while that of migration state increases (Figures 6B,  C) . At 2.0 µg/ml of 4B4, invadopodia function was totally halted and cells migrated continuously. Higher concentrations of blocking antibody also blocked migration and caused cell detachment from the gelatin layer (≥4.0 µg/ml). Collectively, these results indicate that ECM-β1 integrin interactions are involved in balancing invadopodia-related dynamics and frequency of switching between invadopodia and cell migration (Figure 6D ).
Discussion
Invadopodia assembly and function has been well studied as a measure of cancer cell invasiveness, but the relationship between invadopodia and cell translocation and the dynamics of these events were never directly addressed. Here, we demonstrate, for the first time, that cancer cells with invadopodia repeatedly oscillate between invadopodia and migration states. The degree of ECM cross-linking controls the balance between the two states via the level of β1 integrin activity. Moreover, ECM cross-linking controls invadopodia dynamics and function, which involve calcium-dependent MT1-MMP delivery to plasma membrane and protrusion-retraction cycles.
The increase in ECM cross-linking has been previously demonstrated to increase the number of focal adhesions (22) and invadopodia (2, 14, 33) .Next, stiffness of ECM has been reported to affect invadopodia numbers and activity (15) . Finally, either an increase in ECM stiffness or mechanical stretching of ECM layer have been demonstrated to increase MMP expression (34, 35) .Here, we show that the increase in ECM cross-linking affects invadopodiarelated dynamics and their ECM degrading function, as well as invadopodia turnover and the frequency of cell switching between invadopodia and migration. While the number of precursors plateaus with the increase in cross-linking, the number of mature invadopodia demonstrates a pronounced biphasic trend, suggesting that the increase in cross-linking effect may be more important in later steps of invadopodia assembly, such as maturation and MT1-MMP delivery steps. Our data on MT1-MMP recycling confirms this hypothesis. Collectively, our data demonstrate that intermediate level of ECM cross-linking supports highest speeds of protrusive cycles, as well as the most frequent MT1-MMP delivery via Ca 2+ oscillations, while making invadopodia more stable, resulting in a peak of degradative activity. Furthermore, extent of ECM-β1-integrin interactions dictates the length of time that a cell can spend in invadopodia state and the frequency of switching between migration and invadopodia states.
Previous quantitative studies in both invadopodia, generated by cancer cells (13) and podosomes, generated by macrophages or dendritic cells (11, 36, 37) , have shown an oscillatory behavior of the structure core, reflecting protrusion-retraction cycles. Intensity fluctuations in the core actin and cortactin content are a direct measure of the vertical movement of the protrusion tip" digging" into the ECM (11). Similar oscillations were seen in stiffness levels of the podosome structure itself, as measured by AFM (36) . Lengths of protrusion-retraction cycles (i.e. core oscillations) reported in various cell types were 300-900 seconds (11, 13) . Elimination of such cycles was seen with perturbations of actin core by inhibition of ROCK or myosin light chain kinase (11) or inhibition of cortactin phosphorylation (13) . Our data suggests that the cell "sensing" of ECM cross-linking translates into frequency of protrusion-retraction cycles in a coordinated fashion. Thus, ECM cross-linking degree optimal for maximum degradation is in coordination with fastest protrusion-retraction cycles, as well as highest frequencies of calcium spikes and MT1-MMP delivery. Interestingly, coordination between calcium spikes and oscillations in cortical actin (as well as N-WASP and PI(4,5)P2) was recently demonstrated to be essential in vesicle secretion in leukemia cells (38, 39) .
In breast carcinoma (7) , as well as metastatic melanoma (40) , β1-integrin is localized to invadopodia. β1-Integrin is also highly expressed in breast carcinoma compared to β3 and β5 and is necessary for invadopodium maturation, while β3 role focuses on general adhesions. Our model and results of blocking ECM-integrin β1 interactions suggest that the balance between migration and invadopodia states can be altered via ECM-β1-integrin binding levels. Previous reports of dose-response to soluble factors such as EGF, demonstrated similar, biphasic trends of invadopodia numbers and/or chemotactic migration to increasing EGF concentrations (41) (42) (43) . Taken together, these data suggest that conditions in the extracellular environment cannot be directly taken as having a positive or negative effect on motility or invadopodial functions. Cells continuously adapt their behavior to match the conditions encountered at extracellular environment, and this may include reverting to their invasive behaviors. It is possible that each stage of invadopodia assembly contains equilibrium points, and those invadopodia that do not reach stable conformation are continuously eliminated. Such a model is strengthened by a recent mathematical study on focal adhesion growth (44) suggesting that focal adhesions grow to the stable, equilibrium length. While the adhesions that did not reach equilibrium fully disassemble, those that surpass equilibrium size go through partial disassembly. Finally, stable focal adhesion size was found to be in direct relationship with ECM stiffness. In conclusion, our observations suggest the importance of considering non-linear relationships between cells and their immediate environments, which are further complicated by receptor transactivation and inherent heterogeneities in cell transcription levels.
These findings suggest the possibility of targeting invadopodia via ECM-modulation treatments. As invadopodia in vivo are necessary for intravasation (19) and extravasation (3) and hence, metastasis (19) , understanding relationships between the ECM and invadopodia carries powerful implications for future chemotherapies. If invadopodia and their degradative activity can be destabilized by minute changes in ECM cross-linking, this might potentially turn off the cancer cell metastatic potential. In vivo, there are several enzymes catalyzing covalent cross-links of collagen and elastin in cancer. This includes LOX, PLOD and TGII enzymes, all of which were linked to increased cancer cell motility and metastasis (45) (46) (47) . Additionally, ECM cross-linking can be induced by non-enzymatic glycation between sugars and proteins, resulting in advanced glycation products (AGEs), which were shown to increase invasion in cancer cells (48) . Reduction of ECM cross-linking via inhibitors specifically designed for LOX, PLOD2 or TGII (42, 49, 50) , as well as inhibitors of glycation such as flavonoids or aspirin (51) are likely to contribute towards invadopodia reduction. Our work suggests that such inhibitors can be valuable in reducing metastatic potential in neoadjuvant therapy.
Methods
Cell Culture
Mouse breast carcinoma line, Cerulean-cortactin-MTLn3, were a gift from Dr. Ved Sharma, Albert Einstein College of Medicine (Sharma et al. 2013 ). Cells were cultured in α-MEM (Gibco, Thermofisher Scientific, Waltham, MA) supplemented with 5 % FBS (Gemini Bio-Products, West Sacramento, CA), Penicillin/Streptomycin mixture (Gibco, Thermofisher Scientific, Waltham, MA) and 0.5 mg/ml G418 (Sigma-Aldrich). Human cell lines MDA-MB-231 and Hs-578T (ATCC, Manassas, VA) cells were cultured in DMEM (Gibco, Thermofisher Scientific, Waltham, MA) supplemented with 10% FBS and 1% Penicillin/Streptomycin. For Hs-578T cells, 1 mM Pyruvate (Gibco, Thermofisher Scientific, Waltham, MA) and 0.01 mg/ml Bovine insulin (Sigma-Aldrich, St. Louis, MO) were added to the culture media.
Cumulative degradation of gelatin layer
MTLn3, MDA-MB-231 and Hs578T cells were cultured on gelatin-coated plates described previously (52) . Briefly, acid- 60,000 cells per dish were plated for 18 hours on 35 mm Mattek. Cells were fixed with 4% v/v paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) for 15 min and permeabilized with 0.1% Triton X-100 (Sigma-Aldrich, St. Louis, MO) for 10 min. Fixed cells were then blocked in 1% BSA (fraction V, Sigma-Aldrich, St. Louis, MO) and 1% FBS for 2 hours, incubated at 1:100 with anti-cortactin antibody (ab-33333, Abcam, Cambridge, UK) for 2 hours, followed by 2 hours incubation with Alexa-Fluor-633 (1:250) and Alexa-Fluor-546-Phalloidin (1:250) (Abcam, Cambridge, UK).
Imaging of the invadopodia precursors and cumulative degradation at 18 h were performed using an Olympus Fluoview 1200 confocal microscope (Olympus, Tokyo, Japan) with sequential imaging of 6 x 1 μm z-sections/stack. Invadopodia degradation was assessed by quantifying the area of degradation per cell and the number of invadopodia precursors (colocalization of actin and cortactin) per cell at each condition in Fiji (53) . For area of degradation, thresholding and particle size analysis were performed using Fiji. Experiments were done in triplicates, by imaging >10 fields of view, >100 cells in each sample.
Cumulative degradation of 3D collagen I
100,000 MTLn3 cells were suspended in 100 μl of collagen mixture containing: 1.5 mg/ml collagen (Corning, Tewksbury, MA), 50 mM Tris-HCl, 2.5 mM CaCl2, 1 mM DTT (Sigma-Aldrich, St. Louis, MO), 0.15 mg/ml FITC-DQ collagen I (Molecular Probes, Thermofisher Scientific, Waltham, MA), and transglutaminase II (TGII; R&D Systems, Minneapolis, MN) at 1:50,000-1:800,000 dilution. Similarly to GTA, TGII crosslinks free amine groups of glutamine and lysine residues of collagen I (27) . The mixture was pipetted in a 35-mm MatTek dish and incubated at 37°C for 30 min. 2 ml of media (α-MEM/5% FBS) was pipetted into the plate. At 0 h and 42 h, 10 image stacks (20 x 5 μm) were collected. Olympus Fluoview FV1200 confocal microscope (Olympus, Tokyo, Japan) was used, with 488-nm laser excitation.
Invadopodia degradation was quantified by subtracting the FITC-DQ collagen fluorescence at 42 h from the background fluorescence detected in the same sample at 0 h. The result was expressed as degraded area in μm 2 /cell. Measurements were done in 10 fields of view per sample, with three biological repeats per condition.
Crosslinking degree measurements
Measurement of crosslinking degree followed previously published techniques (27, 54) . Briefly, 0.2% w/v gelatin samples were mixed with 0.0%-5.0% v/v GTA and incubated on ice for 10 min. Crosslinking was quenched with 5 mg sodium borohydride for 15 minutes. For collagen, mixture of 1.5 mg/ml collagen I in PBS, 50 mM Tris-HCl, 2.5 mM CaCl2, 1mM DTT was crosslinked with 1:0.5K-1:800K TGII:collagen at 37°C for 30 minutes.
Uncrosslinked amino groups were neutralized by incubation with of 4% NaHCO3 and 0.5% trinitroben zenesulfonic acid (TNBS, Sigma, St. Louis, MO) for 2 h at 37°C in the dark. Finally, samples were incubated at 37°C for 1 h with 6 M HCL (Sigma, St. Louis, MO). The absorbance was measured at 345 nm using an Infinite M200 pro Tecan plate reader (Tecan, Männedorf, Switzerland).
Live cell imaging
Live cell imaging was performed for invadopodia life time, cortactin fluctuations, and calcium oscillation analysis. In brief, Cerulean-cortactin-MTLn3 cells were cultured on Alexa 488 or 546-gelatin coated MatTek dishes and incubated in culture conditions for 16 hours. For lifetime analysis and cortactin oscillations, media was changed to L15 with 5% FBS, 1:100 Oxyfluor (Oxyrase, Mansfield, OH), and 10 mM sodium lactate (Sigma-Aldrich, St. Louis, MO) as reactive oxygen scavengers. Dishes were placed in a 37 °C live cell imaging chamber and time lapse imaging was performed.on widefield Olympus IX81 microscope (Olympus, Tokyo, Japan) equipped with LED lamp, Hamamatsu Orca 16-bit CCD (Hamamatsu, Hamamatsu city, Japan), automated z-drift compensation IX3-ZDC (Olympus, Tokyo, Japan), automated Prior stage (Prior Scientific, Rockland, MA) and environmental chamber. Olympus 60x 1.4 NA, Oil M Plan Apochromat objective was used.
Measurement of invadopodia stability
Images were captured every 10 minutes for >16 hours (1.67 mHz). Invadopodia lifetimes were measured in Fiji (53) and defined as the time between appearance and disappearance of cortactin punctae. Punctae present at the first or last frames were not taken into the account. Invadopodia stability ratio was defined as the ratio of the number of mature invadopodia (those with lifetime > 50 min (6)) to the total number of invadopodia.
Cortactin oscillations in invadopodia core
Images were collected every 30 seconds (33.3 mHz) for 4 hours. Oscillations of cortactin fluorescence were measured only in mature invadopodia (present >2h). In Fiji (53) we filtered individual invadopodia precursors with Laplacian of Gaussian (LOG 3d) (55) plugin and tracked the center of the invadopodium in all frames by SpotTracker (55) . A custom written ImageJ plugin was used to measure average signal inside the invadopodium as well as 4-8 circular areas inside the cytoplasm at each particular frame. In MATLAB, Fast Fourier Transform (FFT) was applied to the time-resolved cortactin signal in invadopodia and the surrounding cytoplasmic regions. High frequencies from the cytoplasm were removed and the filtered invadopodia signal was returned to the time domain by Inverse FFT. Finally, MATLAB autocorrelation function was used to measure the oscillation frequencies in invadopodia.
Calcium Spikes
After cells were plated for 16 hours, cells were incubated for 15 minutes at room temperature in L15, 2.5 mM probenecid (Life Technologies, Frederick, MD), 2.5 µM Fluo4-AM (Life Technologies, Frederick, MD), and 0.02 % Pluronic (Life Technologies, Frederick, MD) (10) . Cells were then washed twice with PBS and incubated in L15 with 5% FBS for 30 min at 37 C. Time lapse imaging was performed with 5 second intervals (200 mHz) for 1 hour. Cytoplasmic calcium spikes were measured by monitoring intracellular Fluo-4-AM signal over time (10) . In ImageJ, entire cells were used as regions of interest; signal was corrected for bleaching and background by subtracting the fluorescence in adjacent inactive cells. Measurements of inactive cells (~70% of total, <10 spikes per hour) were not taken into account (10, 56) . In MATLAB, power spectrum was applied to the time-resolved signal in the cytoplasm. Dominant frequencies at different conditions were further compared.
Measurement of the MT1-MMP delivery event frequency
To visualize the delivery of MT1-MMP delivery event to the plasma membrane, Hs-578T cells were transiently transfected with MT1-MMPpHluorin 24 hours prior to imaging. Transfection was performed via an electroporation technique, in which 2 µg plasmid vector was mixed with 1x 10 6 cells and 50 µL nucleofection solution R (Lonza, Basel, Switzerland). Nucleofection was then performed on the mixture using program X-001 of a nucleofector device (Lonza, Basel, Switzerland). Transfected cells were then plated in a glass-bottom plate and 24 hours after plating, 30-minute time-lapse movies were captured from the cells using a 488 nm laser. A delivery event was defined as the moment that MT1-MMP flashes appear and the rate of delivery was measured as one over the average of the interval between successive flashes.
β1 integrin blocking assay
The blocking of β1 integrin activity was done using 4B4 β1 integrin blocking antibody (Beckman Coulter) at doses of 0, 0.4, 0.6, and 2 µg/ml to cultures 2 hours after plating the cells. MDA-MB-231 cells were plated at a density of 60,000/x cm 2 on Alexa 488 gelatin-coated dishes and time-lapse movies were recorded. Displacement of the cells over time was measured using Fiji plugin TrackMate. For area of degradation, thresholding and particle size analysis were performed using Fiji. Experiments were done in triplicates, by imaging >10 fields of view, >100 cells in each sample.
Statistical Analysis
One way analysis of variance (ANOVA) statistical analysis with Tukey's multiple comparison post-tests was performed to compare the 2D and 3D invadopodia degradation data. Two-tailed student's t-test was performed for statistical analysis as indicated and statistical significance was defined as * P < 0.05; ** P < 0.01 and *** P < 0.001. Data are shown as means ± SEM. 
